Gentlemen, have you any comments about LJPC's Riquent? Looks like pending FDA approval/nonapproval by October 16th will move this stock in a hurry. TIA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.